Safe Harbor Plans Opifex Combination, Outlines New Ownership Structure and Nasdaq Strategy

Burn After Reading The 30-second intel for operators and investors ⏱ 0:30

Safe Harbor Financial signed a nonbinding term sheet to combine with creator-economy firm Opifex Media, leaving Safe Harbor's existing stakeholders with about 15% of the combined company and Opifex holders about 85%, ahead of an April 19, 2027 Nasdaq deadline.

• Operators: Safe Harbor says its cannabis banking, lending and compliance services would keep operating and the deal is not expected to interrupt existing services. Opifex leadership would control management and most of the board.
• Investors: The 15% stake is calculated before new financing and a 10% incentive plan, so it is not a final figure. No definitive agreement exists, and Opifex's audited financials, the valuation and the contingent value right terms are still pending.
• Do now: Watch for Opifex's financial statements and proposed valuation, expected within 15 business days. Safe Harbor says the proposed transaction is not expected to change the services it provides to clients and financial institution partners.

Short on time? You’re done. Want the numbers?Keep reading ↓

The cannabis banking company is pursuing a creator-economy merger ahead of an April 2027 Nasdaq compliance deadline, with a potential reverse split, new financing and a change in corporate control.

Safe Harbor Financial (Nasdaq: SHFS) announced Monday that it has signed a nonbinding term sheet to combine with Opifex Media, a privately held creator-economy company, in a transaction that would leave Safe Harbor’s existing stakeholders with approximately 15% of the combined business.

Under the proposed structure, Opifex security holders would receive newly issued Safe Harbor shares representing 85% of the combined company on a fully diluted basis. Safe Harbor’s allocation could range from 12.5% to 17.5%, depending on an independent valuation and fairness opinion.

The transaction would also place Opifex’s leadership in control of the combined company’s management and most of its board, while Safe Harbor would continue operating its cannabis banking and financial services platform.

The announcement comes less than a week after Nasdaq granted Safe Harbor an additional 180 days, through April 19, 2027, to regain compliance with the exchange’s $1 minimum bid price requirement.

What Existing Shareholders Would Own

The proposed ownership structure is the central financial component of the transaction.

According to the company’s October 26 announcement, Opifex would merge with a newly formed subsidiary of Safe Harbor. Opifex security holders would receive newly issued common shares or, subject to discussions with Nasdaq, a combination of common shares and nonvoting convertible preferred stock.

Following the transaction, Opifex stakeholders would own approximately 85% of the combined company, while Safe Harbor’s existing stakeholders would retain approximately 15%.

The allocation includes Safe Harbor’s common shareholders, Series B preferred shareholders on an as-converted basis, warrant holders, option holders, and restricted stock unit holders.

Importantly, those percentages are calculated before any additional capital raised at closing or shares reserved under a new equity incentive plan.

The term sheet contemplates an incentive plan reserving 10% of fully diluted shares, subject to shareholder approval.

Consequently, the proposed 15% allocation should not be interpreted as a guaranteed final ownership percentage for today’s common shareholders. Their eventual economic interest will depend on the capital structure, outstanding securities, transaction adjustments, and any new financing.

A Valuation of at Least $50 Million for Opifex

The proposed transaction contemplates an Opifex valuation of no less than $50 million, subject to an independent valuation and fairness opinion delivered to Safe Harbor’s board.

Opifex is expected to provide its proposed valuation, financial statements and supporting analysis within 15 business days.

Those materials will be important for evaluating the proposed exchange of ownership. The announcement does not yet provide the audited financial statements needed to assess Opifex’s revenue, profitability, cash generation, or financial position.

The companies also intend to negotiate a contingent value right for Safe Harbor’s existing stakeholders tied to the cannabis financial services business.

Such an arrangement could provide existing stakeholders with additional economic exposure to that business, depending on the terms ultimately negotiated. However, the announcement does not establish the value, payment conditions or structure of the proposed right.

Nasdaq Compliance Is Part of the Transaction

Safe Harbor’s listing status is another significant element of the proposed combination.

On October 20, Nasdaq granted the company an additional compliance period through April 19, 2027, to satisfy the exchange’s minimum bid price requirement.

The companies intend to complete the proposed combination before that deadline.

To meet applicable listing requirements at closing, the transaction may involve registered equity financing from outside investors, as well as a direct investment of up to $1 million, subject to shareholder approval.

Safe Harbor would also seek shareholder approval for a reverse stock split if necessary to meet Nasdaq’s minimum bid price requirement.

A reverse split can increase a company’s nominal share price by reducing the number of outstanding shares, but it does not independently improve its underlying business economics or market valuation.

The company also said it does not intend to draw on its existing equity line of credit with CREO Capital before the proposed transaction closes.

Opifex Would Control the Board and Management

Under the term sheet, the five-member board would include Opifex Chairman Greg Newman, one additional Opifex designee, two independent directors selected by Opifex and approved by Safe Harbor’s nominating and corporate governance committee, and one director designated by Safe Harbor.

The transaction is expected to be accounted for as a reverse acquisition, reflecting the change in control even though Safe Harbor would remain the publicly listed parent company.

Safe Harbor CEO and CFO Terry Mendez described the proposed combination as an opportunity to add a new growth platform while addressing the company’s Nasdaq listing requirements.

“Today’s announcement is an important step for Safe Harbor and our stockholders,” Mendez said.

What Happens to the Cannabis Banking Business?

Despite the proposed change in ownership and corporate direction, Safe Harbor says its cannabis financial services business would continue operating.

The company provides banking-related technology, lending, and compliance services to cannabis businesses and financial institutions. Safe Harbor is a financial technology company rather than a bank; regulated banking services are provided through partner institutions.

According to the announcement, its platform has supported the processing of more than $36 billion in cannabis-related transactions across 41 states and territories since inception.

The proposed holding company would operate two principal businesses: Safe Harbor’s cannabis financial services platform and Opifex’s creator-economy operations, which span publishing, music and video.

Opifex Chairman Greg Newman said the company’s strategy involves acquiring and expanding established media businesses, combining their audiences, data and monetization capabilities.

“Our strategy is to acquire and grow platforms that serve creators, connect their audiences and create additional monetization opportunities,” Newman said.

The announcement does not identify operational synergies between the two businesses or quantify expected cost savings, revenue contributions or incremental cash flow.

For cannabis operators and financial institutions using Safe Harbor, the company says the transaction is not expected to interrupt existing services. For investors, however, the proposed combination would substantially change the composition, ownership and governance of the public company.

Preferred Share Conversions Add Another Capital Structure Consideration

In its October 26 Form 8-K, Safe Harbor also disclosed substantial common share issuance related to the conversion of Series B preferred securities.

Between July 1 and October 23, the company issued 23,914,988 common shares upon conversion of 6,545 Series B preferred shares, at an average conversion price of approximately $0.2737 per share.

The company received no additional consideration from those conversions.

The filing separately reported 24,942,735 common shares outstanding as of October 23.

These conversions are distinct from the proposed Opifex transaction, but they underscore the importance of examining Safe Harbor’s existing capitalization when evaluating the ownership allocation contemplated by the merger.

The proposed transaction also requires arrangements for the conversion of outstanding Series B preferred securities at closing, including agreements and necessary consents from their holders.

A Deal That Is Still Far From Final

The companies have not signed a definitive merger agreement.

Their nonbinding term sheet includes a 45-day exclusivity period and establishes a framework for negotiations, but it does not require either party to complete the combination.

Closing would depend on several conditions, including satisfactory due diligence, Opifex’s audited financial statements, independent valuation and fairness opinions, agreements with Series B preferred holders, shareholder and Nasdaq approvals, and any necessary financing.

The companies intend to close before April 19, 2027, the same date as Safe Harbor’s current Nasdaq compliance deadline.

For existing investors, the next important disclosures will be Opifex’s financial statements, the independent valuation, the proposed contingent value right, and the definitive terms governing ownership and financing. The transaction remains proposed, and there is no assurance that it will close on the announced terms or at all. As cannabis companies navigate capital constraints, shareholder dilution, regulatory uncertainty, and shifting investment strategies, these questions will be central to discussions at IgniteIt’s Capital & Policy Summit in Washington, D.C., on November 18. Join industry executives, investors, and policymakers to examine the financial and regulatory forces shaping the next phase of the cannabis industry.